Literature DB >> 34695199

Whole-genome landscape of adult T-cell leukemia/lymphoma.

Yasunori Kogure1, Takuro Kameda2, Junji Koya1, Makoto Yoshimitsu3, Kisato Nosaka4, Jun-Ichirou Yasunaga4, Yoshitaka Imaizumi5, Mizuki Watanabe6, Yuki Saito1,7, Yuta Ito1,8, Marni B McClure1, Mariko Tabata1,9, Sumito Shingaki1, Kota Yoshifuji1,10, Kenichi Chiba11, Ai Okada11, Nobuyuki Kakiuchi12, Yasuhito Nannya12, Ayako Kamiunten2, Yuki Tahira2, Keiichi Akizuki2, Masaaki Sekine2, Kotaro Shide2, Tomonori Hidaka2, Yoko Kubuki2, Akira Kitanaka13, Michihiro Hidaka14, Nobuaki Nakano15, Atae Utsunomiya15, R Alejandro Sica16, Ana Acuna-Villaorduna16, Murali Janakiram16, Urvi Shah16, Juan Carlos Ramos17, Tatsuhiro Shibata18,19, Kengo Takeuchi20,21,22, Akifumi Takaori-Kondo6, Yasushi Miyazaki5, Masao Matsuoka4, Kenji Ishitsuka3, Yuichi Shiraishi11, Satoru Miyano23, Seishi Ogawa12, B Hilda Ye24, Kazuya Shimoda2, Keisuke Kataoka1,25.   

Abstract

Adult T-cell leukemia/lymphoma (ATL) is an aggressive neoplasm immunophenotypically resembling regulatory T cells, associated with human T-cell leukemia virus type-1. Here, we performed whole-genome sequencing (WGS) of 150 ATL cases to reveal the overarching landscape of genetic alterations in ATL. We discovered frequent (33%) loss-of-function alterations preferentially targeting the CIC long isoform, which were overlooked by previous exome-centric studies of various cancer types. Long but not short isoform-specific inactivation of Cic selectively increased CD4+CD25+Foxp3+ T cells in vivo. We also found recurrent (13%) 3'-truncations of REL, which induce transcriptional upregulation and generate gain-of-function proteins. More importantly, REL truncations are also common in diffuse large B-cell lymphoma, especially in germinal center B-cell-like subtype (12%). In the non-coding genome, we identified recurrent mutations in regulatory elements, particularly splice sites, of several driver genes. In addition, we characterized the different mutational processes operative in clustered hypermutation sites within and outside immunoglobulin/T-cell receptor genes and identified the mutational enrichment at the binding sites of host and viral transcription factors, suggesting their activities in ATL. By combining the analyses for coding and noncoding mutations, structural variations, and copy number alterations, we discovered 56 recurrently altered driver genes, including 11 novel ones. Finally, ATL cases were classified into 2 molecular groups with distinct clinical and genetic characteristics based on the driver alteration profile. Our findings not only help to improve diagnostic and therapeutic strategies in ATL, but also provide insights into T-cell biology and have implications for genome-wide cancer driver discovery.
© 2022 by The American Society of Hematology.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 34695199      PMCID: PMC8854674          DOI: 10.1182/blood.2021013568

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   25.476


  47 in total

Review 1.  Integrins: bidirectional, allosteric signaling machines.

Authors:  Richard O Hynes
Journal:  Cell       Date:  2002-09-20       Impact factor: 41.582

2.  The Cancer Genome Atlas Pan-Cancer analysis project.

Authors:  John N Weinstein; Eric A Collisson; Gordon B Mills; Kenna R Mills Shaw; Brad A Ozenberger; Kyle Ellrott; Ilya Shmulevich; Chris Sander; Joshua M Stuart
Journal:  Nat Genet       Date:  2013-10       Impact factor: 38.330

3.  Gains of 2p involving the REL locus correlate with nuclear c-Rel protein accumulation in neoplastic cells of classical Hodgkin lymphoma.

Authors:  Thomas F E Barth; Josée I Martin-Subero; Stefan Joos; Christiane K Menz; Cornelia Hasel; Gunhild Mechtersheimer; Reza M Parwaresch; Peter Lichter; Reiner Siebert; Peter Möoller
Journal:  Blood       Date:  2003-01-02       Impact factor: 22.113

4.  Definition, prognostic factors, treatment, and response criteria of adult T-cell leukemia-lymphoma: a proposal from an international consensus meeting.

Authors:  Kunihiro Tsukasaki; Olivier Hermine; Ali Bazarbachi; Lee Ratner; Juan Carlos Ramos; William Harrington; Deirdre O'Mahony; John E Janik; Achiléa L Bittencourt; Graham P Taylor; Kazunari Yamaguchi; Atae Utsunomiya; Kensei Tobinai; Toshiki Watanabe
Journal:  J Clin Oncol       Date:  2008-12-08       Impact factor: 44.544

5.  North American ATLL has a distinct mutational and transcriptional profile and responds to epigenetic therapies.

Authors:  Urvi A Shah; Elaine Y Chung; Orsi Giricz; Kith Pradhan; Keisuke Kataoka; Shanisha Gordon-Mitchell; Tushar D Bhagat; Yun Mai; Yongqiang Wei; Elise Ishida; Gaurav S Choudhary; Ancy Joseph; Ronald Rice; Nadege Gitego; Crystall Parrish; Matthias Bartenstein; Swati Goel; Ioannis Mantzaris; Aditi Shastri; Olga Derman; Adam Binder; Kira Gritsman; Noah Kornblum; Ira Braunschweig; Chirag Bhagat; Jeff Hall; Armin Graber; Lee Ratner; Yanhua Wang; Seishi Ogawa; Amit Verma; B Hilda Ye; Murali Janakiram
Journal:  Blood       Date:  2018-08-13       Impact factor: 22.113

6.  WDFY4 is required for cross-presentation in response to viral and tumor antigens.

Authors:  Derek J Theisen; Jesse T Davidson; Carlos G Briseño; Marco Gargaro; Elvin J Lauron; Qiuling Wang; Pritesh Desai; Vivek Durai; Prachi Bagadia; Joshua R Brickner; Wandy L Beatty; Herbert W Virgin; William E Gillanders; Nima Mosammaparast; Michael S Diamond; L David Sibley; Wayne Yokoyama; Robert D Schreiber; Theresa L Murphy; Kenneth M Murphy
Journal:  Science       Date:  2018-11-09       Impact factor: 63.714

7.  Inactivation of Capicua drives cancer metastasis.

Authors:  Ross A Okimoto; Frank Breitenbuecher; Victor R Olivas; Wei Wu; Beatrice Gini; Matan Hofree; Saurabh Asthana; Gorjan Hrustanovic; Jennifer Flanagan; Asmin Tulpule; Collin M Blakely; Henry J Haringsma; Andrew D Simmons; Kyle Gowen; James Suh; Vincent A Miller; Siraj Ali; Martin Schuler; Trever G Bivona
Journal:  Nat Genet       Date:  2016-11-21       Impact factor: 38.330

8.  Revised Adult T-Cell Leukemia-Lymphoma International Consensus Meeting Report.

Authors:  Lucy B Cook; Shigeo Fuji; Olivier Hermine; Ali Bazarbachi; Juan Carlos Ramos; Lee Ratner; Steve Horwitz; Paul Fields; Alina Tanase; Horia Bumbea; Kate Cwynarski; Graham Taylor; Thomas A Waldmann; Achilea Bittencourt; Ambroise Marcais; Felipe Suarez; David Sibon; Adrienne Phillips; Matthew Lunning; Reza Farid; Yoshitaka Imaizumi; Ilseung Choi; Takashi Ishida; Kenji Ishitsuka; Takuya Fukushima; Kaoru Uchimaru; Akifumi Takaori-Kondo; Yoshiki Tokura; Atae Utsunomiya; Masao Matsuoka; Kunihiro Tsukasaki; Toshiki Watanabe
Journal:  J Clin Oncol       Date:  2019-01-18       Impact factor: 44.544

9.  Combined burden and functional impact tests for cancer driver discovery using DriverPower.

Authors:  Shimin Shuai; Steven Gallinger; Lincoln Stein
Journal:  Nat Commun       Date:  2020-02-05       Impact factor: 14.919

10.  Pan-cancer analysis of whole genomes identifies driver rearrangements promoted by LINE-1 retrotransposition.

Authors:  Eva G Alvarez; Adrian Baez-Ortega; Jorge Zamora; Fran Supek; Bernardo Rodriguez-Martin; Jonas Demeulemeester; Martin Santamarina; Young Seok Ju; Javier Temes; Daniel Garcia-Souto; Harald Detering; Yilong Li; Jorge Rodriguez-Castro; Ana Dueso-Barroso; Alicia L Bruzos; Stefan C Dentro; Miguel G Blanco; Gianmarco Contino; Daniel Ardeljan; Marta Tojo; Nicola D Roberts; Sonia Zumalave; Paul A W Edwards; Joachim Weischenfeldt; Montserrat Puiggròs; Zechen Chong; Ken Chen; Eunjung Alice Lee; Jeremiah A Wala; Keiran Raine; Adam Butler; Sebastian M Waszak; Fabio C P Navarro; Steven E Schumacher; Jean Monlong; Francesco Maura; Niccolo Bolli; Guillaume Bourque; Mark Gerstein; Peter J Park; David C Wedge; Rameen Beroukhim; David Torrents; Jan O Korbel; Inigo Martincorena; Rebecca C Fitzgerald; Peter Van Loo; Haig H Kazazian; Kathleen H Burns; Peter J Campbell; Jose M C Tubio
Journal:  Nat Genet       Date:  2020-02-05       Impact factor: 38.330

View more
  8 in total

Review 1.  The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms.

Authors:  Rita Alaggio; Catalina Amador; Ioannis Anagnostopoulos; Ayoma D Attygalle; Iguaracyra Barreto de Oliveira Araujo; Emilio Berti; Govind Bhagat; Anita Maria Borges; Daniel Boyer; Mariarita Calaminici; Amy Chadburn; John K C Chan; Wah Cheuk; Wee-Joo Chng; John K Choi; Shih-Sung Chuang; Sarah E Coupland; Magdalena Czader; Sandeep S Dave; Daphne de Jong; Ming-Qing Du; Kojo S Elenitoba-Johnson; Judith Ferry; Julia Geyer; Dita Gratzinger; Joan Guitart; Sumeet Gujral; Marian Harris; Christine J Harrison; Sylvia Hartmann; Andreas Hochhaus; Patty M Jansen; Kennosuke Karube; Werner Kempf; Joseph Khoury; Hiroshi Kimura; Wolfram Klapper; Alexandra E Kovach; Shaji Kumar; Alexander J Lazar; Stefano Lazzi; Lorenzo Leoncini; Nelson Leung; Vasiliki Leventaki; Xiao-Qiu Li; Megan S Lim; Wei-Ping Liu; Abner Louissaint; Andrea Marcogliese; L Jeffrey Medeiros; Michael Michal; Roberto N Miranda; Christina Mitteldorf; Santiago Montes-Moreno; William Morice; Valentina Nardi; Kikkeri N Naresh; Yasodha Natkunam; Siok-Bian Ng; Ilske Oschlies; German Ott; Marie Parrens; Melissa Pulitzer; S Vincent Rajkumar; Andrew C Rawstron; Karen Rech; Andreas Rosenwald; Jonathan Said; Clémentine Sarkozy; Shahin Sayed; Caner Saygin; Anna Schuh; William Sewell; Reiner Siebert; Aliyah R Sohani; Reuben Tooze; Alexandra Traverse-Glehen; Francisco Vega; Beatrice Vergier; Ashutosh D Wechalekar; Brent Wood; Luc Xerri; Wenbin Xiao
Journal:  Leukemia       Date:  2022-06-22       Impact factor: 12.883

2.  Requirement for TP73 and genetic alterations originating from its intragenic super-enhancer in adult T-cell leukemia.

Authors:  Jolynn Zu Lin Ong; Rui Yokomori; Regina Wan Ju Wong; Tze King Tan; Ryuzo Ueda; Takashi Ishida; Shinsuke Iida; Takaomi Sanda
Journal:  Leukemia       Date:  2022-07-30       Impact factor: 12.883

Review 3.  Functional and Pathogenic Roles of Retroviral Antisense Transcripts.

Authors:  Kosuke Toyoda; Masao Matsuoka
Journal:  Front Immunol       Date:  2022-04-29       Impact factor: 8.786

Review 4.  Genetic Alterations in Adult T-Cell Leukemia/Lymphoma: Novel Discoveries with Clinical and Biological Significance.

Authors:  Shugo Sakihama; Kennosuke Karube
Journal:  Cancers (Basel)       Date:  2022-05-12       Impact factor: 6.575

5.  Exploration of mRNAs and miRNA classifiers for various ATLL cancer subtypes using machine learning.

Authors:  Mohadeseh Zarei Ghobadi; Rahman Emamzadeh; Elaheh Afsaneh
Journal:  BMC Cancer       Date:  2022-04-21       Impact factor: 4.638

Review 6.  Specialized Intercellular Communications via Tunnelling Nanotubes in Acute and Chronic Leukemia.

Authors:  Alessandro Allegra; Mario Di Gioacchino; Gabriella Cancemi; Marco Casciaro; Claudia Petrarca; Caterina Musolino; Sebastiano Gangemi
Journal:  Cancers (Basel)       Date:  2022-01-28       Impact factor: 6.639

7.  Feasibility and clinical utility of comprehensive genomic profiling of hematological malignancies.

Authors:  Suguru Fukuhara; Yuji Oshikawa-Kumade; Yasunori Kogure; Sumito Shingaki; Hirokazu Kariyazono; Yoshiya Kikukawa; Junji Koya; Yuki Saito; Mariko Tabata; Kota Yoshifuji; Kota Mizuno; Akiko Miyagi-Maeshima; Hiromichi Matsushita; Masanaka Sugiyama; Chitose Ogawa; Yoshihiro Inamoto; Takahiro Fukuda; Masato Sugano; Nobuhiko Yamauchi; Yosuke Minami; Makoto Hirata; Teruhiko Yoshida; Takashi Kohno; Shinji Kohsaka; Hiroyuki Mano; Yuichi Shiraishi; Seishi Ogawa; Koji Izutsu; Keisuke Kataoka
Journal:  Cancer Sci       Date:  2022-06-17       Impact factor: 6.518

Review 8.  Clonal Selection and Evolution of HTLV-1-Infected Cells Driven by Genetic and Epigenetic Alteration.

Authors:  Makoto Yamagishi; Yutaka Suzuki; Toshiki Watanabe; Kaoru Uchimaru
Journal:  Viruses       Date:  2022-03-12       Impact factor: 5.048

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.